Ragaz J .1988 .Hepatocellular carcinoma: a comparison of oriental and Caucasianpatients. AmJSurg, 155 : 659-62.
Wong F,Choi TK .1988 .Surgery of liver and Biliary tract. LondonC:hurchillLivingstone, : 1135-51.
Ahmed M,Qureshi MS,ZuberiSJ MS .1979 .; role in the epidemiology of liver diseases. JPMA, 29 : 23-7.
Chao Y,Chan WK,Huang YS,Teng HC,Wang SS,Lui WY .1996 .eta! Phase II of flutamide in the treatment of hepatocellularcarcinoma. Cancel, 77 : 635-9.
Ram AM,Novell JR,Suppl I) . .Intraarterial radiotherapy with 131 iodine-lipiodol for irresectable hepatocellular carcinoma. , : A17.
Madden MV,Krige E.,Baily S,Beningfield ST .1993 .Randomised trial of targeted chemotherapy with lipiodol and 5 epidoxorubicin compared with symptomatic treatment for hepatoma. Gut, 34 : 1598-600.
Rossi P,Rossi M,Clementi M,Pizzamigho M.Bezzi M . .SalvatorFiM. Proc Euro SemDiaginternRadio! Herakhon1, 994 : 315-20.
Novell JR,Dick R,Hobbs KE .1995 .Epirubicin-lipiodal chemotherapy versus 131 iodine - lipioidol radiotherapyin the treatment of unresectable hepatocellular carcinoma. Cancer, 76 : 2202-10.
de HerderWW .1996 .. Hofland IJ. Octreotide. NEngJMed, 334 : 246-54.
Reubi JC,Kvols L . .Distribution of somatostain receptors in normal and tumor tissue. Metabolism, 39(Suppl 2) : 78-81.
Reubi JC .1991 .The role of somatostotin and its analogues, in the diagnosis and treatment of tumors. EndocRev, 12 : 450-82.
Thermos K,Vasilaki A .1998 .Treatment of hepatocellular carcinoma with octretide; a randomised controlled study. Gut, 42 : 442-7.
.1994 .Subtype selectivity of peptide analogues for all five cloned human somatostain receptors (hsstr 1-5. Endocrinology, 125 : 2814-7.
Yamada Y,Shimatsu A .1994 .-995 in treatment of human endocrine tumors. JCiin invest, 93 : 1321-5.
.1994 .All five cloned human somatostatinreceptors (hsstr 1-5) are functionally coupled to adenyl cyclase. Biochem Biophys Res Common, 198 : 605-12.
Reily C .1989 .Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc NatAcadSci USA, 86 : 2003-7.
Scholly AV,Reeding TW .1987 .Somatostain analogue as adjuncts to agonists of lutenizing hormone releasing hormone in the treatment of experimental prostate cancer. Proc NatAcadSciUSA, 72 : 75-9.
Caplin ME .1996 .The CCK-K gastrin receptor. hepatocellulor carcinomaGut, (Suppl 1) : A16.
Piva A,Miguet P Dhumeaux D . .Treatment of hepatoceller carcinoma. in hepatology 93: ParisohnLibbey Eurptext1, 993 : 18-22.